Redburn Atlantic Adjusts Price Target on Bristol-Myers Squibb to $52 From $53, Maintains Neutral Rating
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
57.42 USD | -3.84% |
|
-2.91% | +1.52% |
Feb. 06 | Health Care Climbs After Lilly Earnings - Health Care Roundup | DJ |
Feb. 06 | Trump faces pressure from US industry over China tariff on medicines | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration